Navigation Links
China BCT Reports First Quarter 2010 Results

LIUZHOU CITY, Guangxi, China, May 21 /PRNewswire-Asia-FirstCall/ -- China BCT Pharmacy Group, Inc., (OTC Bulletin Board: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the first quarter ended March 31, 2010.

    First Quarter 2010 Highlights
    -- Revenue increased 5.2% to $34.0 million year over year
    -- Gross profit was up slightly year over year to $8.9 million
    -- Operating income decreased 11.5% to $6.2 million year over year
    -- GAAP net income was $4.2 million in the 2010 first quarter as compared
       to $5.0 million in the year ago quarter
    -- Excluding the non-cash, non-operating charge related to change in the
       fair value of warrant liabilities, non-GAAP adjusted net income was
       $4.5 million

"While we grew sales by leveraging our strong relationships with suppliers and customers, a shift in product mix and significant investments in staffing and marketing negatively affected our profit in the first quarter," commented Mr. Hui Tian Tang, Chairman and Chief Executive Officer of China BCT Pharmacy Group, Inc. "We expect that these strategic investments in our business will return substantial gains over time. As the Chinese government's health care reforms expand, we are already seeing a growing number of our medi-care pharmacy customers receiving state health insurance coverage. Further, our recent acquisition of 48 retail pharmacy stores in Guangxi Province has further expanded our retail footprint to strengthen our leadership in the region and create new growth dri

SOURCE China BCT Pharmacy Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
2. OriGene Technologies, Inc. to Build the Worlds Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China
3. China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results
4. Renhuang Pharmaceuticals Exhibits All-Natural Products at the 63rd PHARMACHINA Fair
5. China Pharma Holdings, Inc. CEO to Speak at Brean Murray, Carret & Co. 2010 Life Sciences Summit
6. China Sky One Medical Provides Sales Forecast for 13 New Products
7. China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity
8. Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
9. China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results
10. China Sky One Medical Announces Preliminary First Quarter 2010 Results; Reschedules Earnings Conference Call
11. China Medicine Announces Conference Call to Discuss First Quarter 2010 Results
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... company focused on the development of autologous cell therapies, today ... partnering meetings taking place in the month of October: ... Partnering Forum RepliCel will be presenting at the ... on the Mesa to be held October 7-9 in ...
(Date:10/8/2015)... ... October 08, 2015 , ... Talon Innovations, a provider of Precision Machined ... announces that it is one of three finalists for the Minnesota Business magazine’s Manufacturing ... September 25 Talon Innovations was recognized as a nominee for this competitive award. ...
(Date:10/7/2015)... 2015 --> ... for largest bioinformatics market share due to ... and development process says this research report ... . --> . ... applications, the bioinformatics market is segmented into ...
(Date:10/7/2015)... ... 07, 2015 , ... The Riordan-McKenna Institute ( ) ... on the latest advances in adult stem cell therapy for orthopedic conditions and ... the Hilton Dallas/Southlake Town Square in Southlake, Texas. , RMI offers non-surgical stem ...
Breaking Biology Technology:
... , ANAHEIM, Calif., July 23 Varian Medical ... of new and updated products that improve and simplify the processes ... be a new version of the Eclipse(TM) radiotherapy treatment planning system, ... clinical flexibility. The new software release received FDA 510(k) clearance ...
... , , SUNNYVALE, Calif., ... of endovascular devices for the treatment of chronic total occlusions (CTOs), ... Chief Operating Officer. Chris previously held the position of Executive VP, ... experience in Medical Devices including the last 2 years at FlowCardia. ...
... , , DALLAS, July 23 ... S S PHARMACEUTICALS, INC. ... SpePharm , is collecting data from a post approval study of MuGard ... of oral mucositis. In a multi-center study expected to enroll a total of ...
Cached Biology Technology:
(Date:9/28/2015)... , Sept. 28, 2015  The monitoring of ... and body temperature, is an essential component of ... indicators of deterioration in a patient,s condition. However, ... signs are typically taken during routine observation rounds ... a patient deteriorates between these observation rounds, the ...
(Date:9/26/2015)... -- Results of a TactioRPM pilot project in a ... Stanford Medicine X Conference. In a presentation titled ... Devices and Pharmacogenomics", Roger Simard , Pharmacist ... senior patients equipped with connected health devices and ... TactioRPM remote patient monitoring platform were empowered to ...
(Date:9/10/2015)... , Sept. 10, 2015 Report Details ... Study Reveals Selling Opportunities and Revenue Prospects to ... future of biologics, especially new drug classes? Get ... stay ahead with exclusive market data and industry ... trends, developments, results, opportunities and sales predictions. ...
Breaking Biology News(10 mins):
... tips below highlight research in the ESA journals Frontiers ... Ecological Applications and Ecological Monographs . ... but may invite invasives , ... of fire fuel reduction methods under the U.S. National Fire ...
... in northern Ghana difficult enough. It doesn,t help that in ... power tractors for planting crops or to power grain milling. ... from some native trees may be able to help. ... create biodiesel from the seeds of trees that are common ...
... decades after the Exxon Valdez oil spill devastated a vast ... Arctic would be unable to effectively manage a large oil ... As the 20th anniversary of the Exxon Valdez spill approaches ... on new offshore oil development in the Arctic until technologies ...
Cached Biology News:
Mouse monoclonal [88B] to nicotinic Acetylcholine Receptor ( Abpromise for all tested applications)....
PPIF Antibody...
Glutamate Receptor 5/1a...
... Rabbit monoclonal [EP282Y] to ... for all tested applications). ... peptide corresponding to residues in ... synthetase. Entrez ...
Biology Products: